How can monoclonal antibodies be harnessed against neglected tropical diseases and other infectious diseases?
AH Laustsen - Expert opinion on drug discovery, 2019 - Taylor & Francis
Introduction: Monoclonal antibody-based therapies now represent the single-largest class of
molecules undergoing clinical investigation. Although a handful of different monoclonal …
molecules undergoing clinical investigation. Although a handful of different monoclonal …
How can monoclonal antibodies be harnessed against neglected tropical diseases and other infectious diseases?
AH Laustsen - Expert opinion on drug discovery, 2019 - pubmed.ncbi.nlm.nih.gov
Introduction: Monoclonal antibody-based therapies now represent the single-largest class of
molecules undergoing clinical investigation. Although a handful of different monoclonal …
molecules undergoing clinical investigation. Although a handful of different monoclonal …
How can monoclonal antibodies be harnessed against neglected tropical diseases and other infectious diseases?
AH Laustsen - Expert Opinion on Drug Discovery, 2019 - europepmc.org
Introduction: Monoclonal antibody-based therapies now represent the single-largest class of
molecules undergoing clinical investigation. Although a handful of different monoclonal …
molecules undergoing clinical investigation. Although a handful of different monoclonal …
How can monoclonal antibodies be harnessed against neglected tropical diseases and other infectious diseases?
AH Laustsen - Expert Opinion on Drug Discovery, 2019 - orbit.dtu.dk
Introduction: Monoclonal antibody-based therapies now represent the single-largest class of
molecules undergoing clinical investigation. Although a handful of different monoclonal …
molecules undergoing clinical investigation. Although a handful of different monoclonal …